6 reports

The molecules developed by Companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ##, ##, ## and ## respectively.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

One patient had a fatal SAE, which was not drug related.

  • Antifungal
  • Autoimmune Disease
  • Pharmaceutical
  • United States
  • Product Initiative

One patient had a fatal SAE, which was not drug related.

  • Antifungal
  • Autoimmune Disease
  • Cancer
  • United States
  • Product Initiative

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Autoimmune Disease
  • Therapy
  • United States
  • SCYNEXIS, Inc.

This explains the need for a high drug dose of IXF-## as supported by the findings of the recently published post-hoc analysis.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

One patient had a fatal SAE, which was not drug related.

  • Antifungal
  • Autoimmune Disease
  • Blood Disease
  • United States
  • Product Initiative